Skip to Content
Merck
  • c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2.

c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2.

Proceedings of the National Academy of Sciences of the United States of America (2014-11-05)
Rom Keshet, Zina Bryansker Kraitshtein, Matan Shanzer, Julia Adler, Nina Reuven, Yosef Shaul
ABSTRACT

Adipocyte differentiation, or adipogenesis, is a complex and highly regulated process. A recent proteomic analysis has predicted that the nonreceptor tyrosine kinase Abelson murine leukemia viral oncogene (c-Abl) is a putative key regulator of adipogenesis, but the underlying mechanism remained obscure. We found that c-Abl was activated during the early phase of mouse 3T3-L1 preadipocyte differentiation. Moreover, c-Abl activity was essential and its inhibition blocked differentiation to mature adipocytes. c-Abl directly controlled the expression and activity of the master adipogenic regulator peroxisome proliferator-activator receptor gamma 2 (PPARγ2). PPARγ2 physically associated with c-Abl and underwent phosphorylation on two tyrosine residues within its regulatory activation function 1 (AF1) domain. We demonstrated that this process positively regulates PPARγ2 stability and adipogenesis. Remarkably, c-Abl binding to PPARγ2 required the Pro12 residue that has a phenotypically well-studied common human genetic proline 12 alanine substitution (Pro12Ala) polymorphism. Our findings establish a critical role for c-Abl in adipocyte differentiation and explain the behavior of the known Pro12Ala polymorphism.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-LCP1 (ab1) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-FABP4 antibody produced in rabbit, affinity isolated antibody